Your browser doesn't support javascript.
A lightspeed approach to pandemic drug development.
Anderson, Annaliesa S.
  • Anderson AS; Worldwide Research, Development & Medical, Pfizer Inc., Pearl River, NY, USA. Annaliesa.Anderson@pfizer.com.
Nat Med ; 28(8): 1538, 2022 08.
Article in English | MEDLINE | ID: covidwho-1991644

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / Drug Development Type of study: Prognostic study Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2022 Document Type: Article Affiliation country: S41591-022-01945-6

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / Drug Development Type of study: Prognostic study Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2022 Document Type: Article Affiliation country: S41591-022-01945-6